294 related articles for article (PubMed ID: 33965624)
21. Strategies for Precise Engineering and Conjugation of Antibody Targeted-nanoparticles for Cancer Therapy.
Guo YY; Huang L; Zhang ZP; Fu DH
Curr Med Sci; 2020 Jun; 40(3):463-473. PubMed ID: 32681251
[TBL] [Abstract][Full Text] [Related]
22. Targeting tumor glycolysis by a mitotropic agent.
Ganapathy-Kanniappan S
Expert Opin Ther Targets; 2016; 20(1):1-5. PubMed ID: 26420565
[TBL] [Abstract][Full Text] [Related]
23. Emergence of nanomedicine as cancer targeted magic bullets: recent development and need to address the toxicity apprehension.
Rahman M; Ahmad MZ; Kazmi I; Akhter S; Afzal M; Gupta G; Sinha VR
Curr Drug Discov Technol; 2012 Dec; 9(4):319-29. PubMed ID: 22725687
[TBL] [Abstract][Full Text] [Related]
24. Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery.
Chen Z; Zhang L; Song Y; He J; Wu L; Zhao C; Xiao Y; Li W; Cai B; Cheng H; Li W
Biomaterials; 2015 Jun; 52():240-50. PubMed ID: 25818430
[TBL] [Abstract][Full Text] [Related]
25. Targeted anticancer therapy: overexpressed receptors and nanotechnology.
Akhtar MJ; Ahamed M; Alhadlaq HA; Alrokayan SA; Kumar S
Clin Chim Acta; 2014 Sep; 436():78-92. PubMed ID: 24836529
[TBL] [Abstract][Full Text] [Related]
26. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
Gerhards NM; Rottenberg S
Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
[TBL] [Abstract][Full Text] [Related]
27. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial-targeted nanoparticles: Delivery and therapeutic agents in cancer.
Ganji C; Muppala V; Khan M; Nagaraju GP; Farran B
Drug Discov Today; 2023 Mar; 28(3):103469. PubMed ID: 36529353
[TBL] [Abstract][Full Text] [Related]
29. Redox Potential and ROS-Mediated Nanomedicines for Improving Cancer Therapy.
Glass SB; Gonzalez-Fajardo L; Beringhs AO; Lu X
Antioxid Redox Signal; 2019 Feb; 30(5):747-761. PubMed ID: 28990403
[TBL] [Abstract][Full Text] [Related]
30. Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions.
Raj R; Mongia P; Kumar Sahu S; Ram A
Curr Drug Targets; 2016; 17(2):206-28. PubMed ID: 26201484
[TBL] [Abstract][Full Text] [Related]
31. Application of Graphene and its Derivatives in Cancer Diagnosis and Treatment.
Ghanbarzadeh S; Hamishehkar H
Drug Res (Stuttg); 2017 Dec; 67(12):681-687. PubMed ID: 28898912
[TBL] [Abstract][Full Text] [Related]
32. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
Zhao X; Ye Y; Ge S; Sun P; Yu P
Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
[TBL] [Abstract][Full Text] [Related]
33. Mitochondria-targeted nanoparticles (mitoNANO): An emerging therapeutic shortcut for cancer.
Tabish TA; Hamblin MR
Biomater Biosyst; 2021 Sep; 3():100023. PubMed ID: 36824307
[TBL] [Abstract][Full Text] [Related]
34. Biomedical application of graphene: From drug delivery, tumor therapy, to theranostics.
Song S; Shen H; Wang Y; Chu X; Xie J; Zhou N; Shen J
Colloids Surf B Biointerfaces; 2020 Jan; 185():110596. PubMed ID: 31707226
[TBL] [Abstract][Full Text] [Related]
35. Friend or foe? Mitochondria as a pharmacological target in cancer treatment.
Dickerson T; Jauregui CE; Teng Y
Future Med Chem; 2017 Dec; 9(18):2197-2210. PubMed ID: 29182013
[TBL] [Abstract][Full Text] [Related]
36. Innovative nano-carriers in anticancer drug delivery-a comprehensive review.
Dong P; Rakesh KP; Manukumar HM; Mohammed YHE; Karthik CS; Sumathi S; Mallu P; Qin HL
Bioorg Chem; 2019 Apr; 85():325-336. PubMed ID: 30658232
[TBL] [Abstract][Full Text] [Related]
37. Folic Acid Conjugated Nanocarriers for Efficient Targetability and Promising Anticancer Efficacy for Treatment of Breast Cancer: A Review of Recent Updates.
Choudhury H; Pandey M; Wen LP; Cien LK; Xin H; Yee ANJ; Lee NJ; Gorain B; Amin MCIM; Pichika MR
Curr Pharm Des; 2020; 26(42):5365-5379. PubMed ID: 32693762
[TBL] [Abstract][Full Text] [Related]
38. Recent Advancements in Mitochondria-Targeted Nanoparticle Drug Delivery for Cancer Therapy.
Xu J; Shamul JG; Kwizera EA; He X
Nanomaterials (Basel); 2022 Feb; 12(5):. PubMed ID: 35269231
[TBL] [Abstract][Full Text] [Related]
39. Mitocans: mitochondrial targeted anti-cancer drugs as improved therapies and related patent documents.
Ralph SJ; Low P; Dong L; Lawen A; Neuzil J
Recent Pat Anticancer Drug Discov; 2006 Nov; 1(3):327-46. PubMed ID: 18221044
[TBL] [Abstract][Full Text] [Related]
40. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]